好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Utilizing Single Cell Immune Profiling to Identify Serum-based Biomarkers for Transient Ischemic Attacks
Cerebrovascular Disease and Interventional Neurology
P2 - Poster Session 2 (5:30 PM-6:30 PM)
3-027

The study’s objective is to utilize single cell CyTOF (mass cytometry by time of flight mass spectrometry) to investigate serum inflammatory changes in transient ischemic attack (TIA) and minor stroke patients versus non-ischemic transient neurologic events (TNEs).

Clinically diagnosing TIAs remains challenging. An accurate serum marker to differentiate TIAs from TNEs would greatly improve treatment.

Patients presenting to the emergency department with transient neurologic symptoms or with minor strokes (NIHSS≤4) were prospectively enrolled. A blood sample was collected within 72 hours, on which CyTOF analysis was completed examining 11 inflammatory markers in 19 single cell populations. These populations also underwent stimulation from lipopolysaccharide (LPS). Mixed ANOVA analysis was performed to evaluate response to stimulation and its differences between the groups.

Patients with TIA/minor stroke (n=10) and TNEs (n=10) were enrolled.  The difference in CREB (cAMP response element binding protein) and NfKB (nuclear factor light chain enhancer of activated B Cells) levels before and after LPS stimulation were evaluated.  Interestingly in the classical monocyte cell population, the change of CREB  levels in response to LPS stimulation was increased in the TIA/minor stroke group compared to the TNE group  (1.64±0.13 versus 1.28±0.42 respectively, indicated by a significant interaction effect between change and group, p=0.020, with Partial Eta Squared ηp2=0.267 suggesting large effect).  NfKB also showed an increased change in response to LPS stimulation in the TIA/minor stroke patients compared to controls (0.88±0.11 versus 0.75±0.14 respectively, p=0.045, ηp2=0.205).  

In our hypothesis generating study, differences exist in inflammatory markers between TIA/minor strokes and TNE patients that can be measured via CyTOF. These findings suggest following an ischemic episode the immune system is more primed to respond to a stimulus. Promising prospects for future TIA serum biomarker studies include CREB and NfKB concentrations with LPS stimulation.

Authors/Disclosures
Kate E. Therkelsen, MD (Stanford University School of Medicine)
PRESENTER
Dr. Therkelsen has nothing to disclose.
No disclosure on file
Michael Mlynash No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Paul M. George, MD, PhD, MSE, FAAN (Stanford Hospital) Dr. George has received personal compensation in the range of $0-$499 for serving as a Consultant for ConductiveBio. Dr. George has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Law firms. The institution of Dr. George has received research support from Conductive Bio. The institution of Dr. George has received research support from NIH. Dr. George has received intellectual property interests from a discovery or technology relating to health care. Dr. George has received personal compensation in the range of $10,000-$49,999 for serving as a Adjudicator with Baim Insititute. Dr. George has a non-compensated relationship as a Board Member with 好色先生 that is relevant to AAN interests or activities. Dr. George has a non-compensated relationship as a International Stroke Council Program committee member with American Heart Association that is relevant to AAN interests or activities.